Subunit Flexibility of Multimeric von Willebrand Factor/Factor VIII Complexes

por Parker, Ernest T., Haberichter, Sandra L., Lollar, Pete
Publicado 2022

Fibronectin binding to von Willebrand factor occurs via the A1 domain

por Keesler, Daniel A., Slobodianuk, Tricia L., Kochelek, Caroline E., Skaer, Chad W., Haberichter, Sandra L., Flood, Veronica H.
Publicado 2021

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure

por Christopherson, Pamela A., Haberichter, Sandra L., Flood, Veronica H., Sicking, Ursula O., Abshire, Thomas C., Montgomery, Robert R.
Publicado 2022

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9

por Garcia, Jessica, Flood, Veronica H., Haberichter, Sandra L., Fahs, Scot A., Mattson, Jeremy G., Geurts, Aron M., Zogg, Mark, Weiler, Hartmut, Shi, Qizhen, Montgomery, Robert R.
Publicado 2019

Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD

por Flood, Veronica H., Johnsen, Jill M., Kochelek, Caroline, Slobodianuk, Tricia L., Christopherson, Pamela A., Haberichter, Sandra L., Udani, Rupa, Bellissimo, Daniel B., Friedman, Kenneth D., Montgomery, Robert R.
Publicado 2018

Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance

por Doherty, Dearbhla, Michelle Lavin, Byrne, Mary, Nolan, Margaret, O’Sullivan, Jamie M., Ryan, Kevin, O’Connell, Niamh M., Haberichter, Sandra L., Christopherson, Pamela A., Di Paola, Jorge, James, Paula D., O’Donnell, James S.
Publicado 2022

Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance

por Ward, Soracha E., O’Sullivan, Jamie M., Moran, Alan B., Spencer, Daniel I. R., Gardner, Richard A., Sharma, Jyotika, Fazavana, Judicael, Monopoli, Marco, McKinnon, Thomas A. J., Chion, Alain, Haberichter, Sandra, O’Donnell, James S.
Publicado 2021

Identifying experts for clinical practice guidelines: perspectives from the ASH Guideline Oversight Subcommittee

por Byrne, Michael, Mattison, Ryan, Bercovitz, Rachel, Lottenberg, Richard, Rezende, Suely M., Silverstein, Roy, Terrell, Deirdra, Kunkle, Rob, Smith, Deion, Bollard, Catherine, Haberichter, Sandra, Holter-Chakrabarty, Jennifer, Pai, Menaka, Cheung, Matthew, Cuker, Adam, Seftel, Matthew, Djulbegovic, Benjamin
Publicado 2023

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A

por Du, Lily M., Nurden, Paquita, Nurden, Alan T., Nichols, Timothy C., Bellinger, Dwight A., Jensen, Eric S., Haberichter, Sandra L., Merricks, Elizabeth, Raymer, Robin A., Fang, Juan, Koukouritaki, Sevasti B., Jacobi, Paula M., Hawkins, Troy B., Cornetta, Kenneth, Shi, Qizhen, Wilcox, David A.
Publicado 2013

Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis

por Kalot, Mohamad A., Husainat, Nedaa, Abughanimeh, Omar, Diab, Osama, El Alayli, Abdallah, Tayiem, Sammy, Madoukh, Bader, Dimassi, Ahmad, Qureini, Aref, Ameer, Barbara, Eikenboom, Jeroen, Giraud, Nicolas, Haberichter, Sandra, Jacobs-Pratt, Vicky, Konkle, Barbara A., McRae, Simon, Montgomery, Robert, O’Donnell, James S., Brignardello-Petersen, Romina, Flood, Veronica, Connell, Nathan T., James, Paula, Mustafa, Reem A.
Publicado 2022